Other News To Note
• Microbix Biosystems Inc., of Toronto, and Zydus Cadila, of Ahmedabad, India, signed a letter of intent to market thrombolytic drug Urokinase in North American markets. Microbix acquired rights to the drug in 2008. Financial terms were not disclosed.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST